William Garrett Nichols - 26 Jan 2026 Form 4 Insider Report for Candel Therapeutics, Inc. (CADL)

Role
Chief Medical Officer
Signature
/s/ Charles Schoch, as Attorney-in-Fact for William Garrett Nichols
Issuer symbol
CADL
Transactions as of
26 Jan 2026
Net transactions value
$0
Form type
4
Filing time
28 Jan 2026, 17:03:33 UTC
Previous filing
30 Jul 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Nichols William Garrett Chief Medical Officer C/O CANDEL THERAPEUTICS, INC., 117 KENDRICK ST., SUITE 450, NEEDHAM /s/ Charles Schoch, as Attorney-in-Fact for William Garrett Nichols 28 Jan 2026 0001618364

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CADL Stock Option (Right to Buy) Award $0 +136,500 $0.000000 136,500 26 Jan 2026 Common Stock 136,500 $6.01 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable in forty-eight (48) equal monthly installments following January 26, 2026, subject to the Reporting Person's continued service on each vesting date.